Cardiovascular

A Wealth of Experience

We have collaborated with our clients on projects to research cardiovascular (CV) disease, CV treatment, and complications and comorbidities of CV disease. Our experience includes:

  • Angina
  • Atrial fibrillation
  • Cardiac dysrhythmia
  • Chronic heart failure
  • Dyslipidemia
  • Heart transplantation
  • Hypertension
  • Hypotension
  • Ischemia
  • Myocardial infarction
  • Peripheral arterial occlusion
  • Peripheral edema
  • Pulmonary arterial hypertension
  • Stroke
  • Sudden cardiac death
  • Venous thromboembolism

Types of Projects

We have implemented studies to help our clients develop strategies in the CV market and to develop and gain market access for products to treat CV diseases and complications arising from treatment of CV illnesses. Recent projects have included:

Our Experts

Caroline Ling
Senior Director and HTA Specialist Market Access and Outcomes Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Christine Poulos
Senior Economist and Head, Health Preference Assessment
Bintu Sherif
Director, Biostatistics
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Cristina Rebordosa
Director, Epidemiology
Manel Pladevall-Vila
Senior Director, Epidemiology
Catherine Masaquel
Senior Director, Market Access and Outcomes Strategy
Elizabeth Andrews
Vice President, Emeritus, Epidemiology
Isobel Pearson
Director, Health Economics, Health Technology Assessment
Sandy Lewis
Senior Director, Patient-Centered Outcomes Assessment
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Kenneth Rothman
Distinguished Fellow, Vice President of Epidemiology Research
Stephanie Earnshaw
Vice President, Health Economics
Thor-Henrik Brodtkorb
Senior Director, Health Economics
Amy Barrett
Director, Patient-Centered Outcomes Assessment
Emma Hawe
Senior Director, Data Analytics and Design Strategy
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Patricia Sacco
Executive Director, Surveys and Observational Studies
Jonathan Graham
Director, Health Economics
Keith Davis
Head, Health Economics
Mary Anthony
Director, Epidemiology
Laurie Zografos
Head, Surveys and Observational Studies
Ari Gnanasakthy
Principal Scientist, Patient-Centered Outcomes Assessment
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Sean Candrilli
Vice President, Health Economics
Josephine Mauskopf
Vice President, Health Economics
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Christopher Graham
Senior Director, Health Economics
Sorrel Wolowacz
Head, European Health Economics
Alicia Gilsenan
Senior Director and Head, Epidemiology
Annete Njue
Director, Market Access and Outcomes Strategy

Selected Recent Cardiovascular Publications

Fortuny J, Gilsenan AW, Cainzos-Achirica M, Cantero OF, Flynn RW, Garcia-Rodriguez L, Kollhorst B, Karlsson P, Linner L, MacDonald TM, Plana E, Ruigomez A, Schink T, Ziemiecki R, Andrews EB. Cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort in a multinational study: study design and comparability of cohorts. Poster presented at the 35th Annual ICPE Conference; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):627.